Cargando…

Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy

Detalles Bibliográficos
Autores principales: Zhao, Ni, Yi, Ye, Cao, Wen, Fu, Xiao, Mei, Nan, Li, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793400/
https://www.ncbi.nlm.nih.gov/pubmed/36582794
http://dx.doi.org/10.3389/fonc.2022.1069999
_version_ 1784859845683314688
author Zhao, Ni
Yi, Ye
Cao, Wen
Fu, Xiao
Mei, Nan
Li, Chunli
author_facet Zhao, Ni
Yi, Ye
Cao, Wen
Fu, Xiao
Mei, Nan
Li, Chunli
author_sort Zhao, Ni
collection PubMed
description
format Online
Article
Text
id pubmed-9793400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97934002022-12-28 Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy Zhao, Ni Yi, Ye Cao, Wen Fu, Xiao Mei, Nan Li, Chunli Front Oncol Oncology Frontiers Media S.A. 2022-12-13 /pmc/articles/PMC9793400/ /pubmed/36582794 http://dx.doi.org/10.3389/fonc.2022.1069999 Text en Copyright © 2022 Zhao, Yi, Cao, Fu, Mei and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhao, Ni
Yi, Ye
Cao, Wen
Fu, Xiao
Mei, Nan
Li, Chunli
Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_full Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_fullStr Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_full_unstemmed Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_short Corrigendum: Serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
title_sort corrigendum: serum cytokine levels for predicting immune-related adverse events and the clinical response in lung cancer treated with immunotherapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793400/
https://www.ncbi.nlm.nih.gov/pubmed/36582794
http://dx.doi.org/10.3389/fonc.2022.1069999
work_keys_str_mv AT zhaoni corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT yiye corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT caowen corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT fuxiao corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT meinan corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy
AT lichunli corrigendumserumcytokinelevelsforpredictingimmunerelatedadverseeventsandtheclinicalresponseinlungcancertreatedwithimmunotherapy